Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coumaphos is a nonvolatile, fat-soluble organophosphate (phosphorothioate) insecticide and acaricide used primarily in veterinary medicine to control ectoparasites such as ticks, mites, flies, and fleas on farm and domestic animals. It acts as a cholinesterase inhibitor, disrupting nerve function in target pests by inhibiting acetylcholinesterase activity. Coumaphos is applied as dips or washes for livestock and has also been used to control Varroa mites in honey bee colonies; however, its use has declined due to resistance development and concerns about toxicity residues. The compound is classified as an extremely hazardous substance in the United States due to its potential for acute organophosphate poisoning[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on coumaphos.